ArticleBritish journal of cancer2023
Years of life lost due to cancer in the United Kingdom from 1988 to 2017.
Article in British journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Disentangling shifting demographic and treatment effects on years of life lost to cancer in Denmark.npj aging · 2026Article
- Understanding age and sex differentials in cancer incidence and mortality: An international population-based study.International journal of cancer · 2026Article
- Trend analysis of cancer mortality and years of life lost in the South of Iran 2004-2019. Joinpoint regression analysis.BMC cancer · 2025Article
- The mortality rate and years of life lost due to cancer in a City of North of Islamic Republic of Iran during the years 2013-2021: joinpoint regression analysis.Annals of medicine and surgery (2012) · 2025Article
- Cancer situation in China: an analysis based on the global epidemiological data released in 2024.Cancer communications (London, England) · 2025Article
- MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances.Oncogene · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundWe investigated the application of years of life lost (YLL) in routine cancer statistics using cancer mortality data from 1988 to 2017.
methodsCancer mortality data for 17 cancers and all cancers in the UK from 1988 to 2017 were provided by the UK Association of Cancer Registries by sex, 5-year age group, and year. YLL, age-standardised YLL rate (ASYR) and age-standardised mortality rate (ASMR) were estimated.
resultsThe annual average YLL due to cancer, in the time periods 1988-1992 and 2013-2017, were about 2.2 and 2.3 million years, corresponding to 4510 and 3823 ASYR per 100,000 years, respectively. During 2013-2017, the largest number of YLL occurred in lung, bowel and breast cancer. YLL by age groups for all cancers showed a peak between 60-64 and 75-79. The relative contributions to incidence, mortality, and YLL differ between cancers. For instance, pancreas (in women and men) made up a smaller proportion of incidence (3%) but bigger proportion of mortality (6 and 5%) and YLL (5 and 6%), whereas prostate cancer (26% of incidence) contributed 13% mortality and 9% YLL.
conclusionYLL is a useful measure of the impact different cancers have on society and puts a higher weight on cancer deaths in younger individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.